Roivant Sciences Ltd. (ROIV) Misses Q2 EPS by 11c

Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q2 EPS of ($0.40), $0.11 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $37.1 million versus the consensus estimate of $29.11 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.

You May Also Be Interested In

• Stifel Starts Roivant Sciences (ROIV) at Buy
• Cargojet Inc. (CJT:CN) (CGGJF) PT Raised to $128 at TD Cowen, maintains bullish call
• Intuit holds investor day, reaffirms fiscal 2027 guidance